(Q64172508)

English

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

PVX-2 (English)

0 references

title

A Randomized Double-Blind, Placebo-controlled Phase II Trial With Safety Run-In of Intramuscular pNGVL4a-Sig/E7(Detox)/HSP70 and TA-CIN for the Treatment of Patients With HPV16+ Atypical Squamous Cells of Undetermined Significance (ASC-US) or Cannot Exclude High Grade SIL (ASC-H) Cytology or Low-grade Squamous Intraepithelial Lesion (LSIL) (English)

0 references

medical condition

atypical squamous cells of the cervix

0 references

start time

30 May 2019

0 references

end time

30 August 2021

0 references

number of participants

122